The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
531256
WO Application Number:
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-payment of the annual fee
Application number:
928106541
WO Publication Number:
EPO Publication Language:
German
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
EP531256;
Dates
Filing date:
26/08/1992
Grant date:
23/04/1997
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
23/04/1997
EP B1 Publication Date:
23/04/1997
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
23/07/1997
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
25/08/2012
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
01/03/1999
Applicant/holder
From:
23/04/1997
Name:
Novartis AG
Address:
4058 Basel, Switzerland (CH)
Domicile Holder
1
Name:
Dr. R. Jorritsma c.s.
From:
23/07/1997
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)
To:
2
Name:
Dr. R. Jorritsma c.s.
From:
15/01/1997
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)